av/csl--big.svg

ASX:CSL

CSL Limited

  • Stock

256.41

+2.11%

5.29

AUD last updated 28/07 01:48:46

Last Close

251.12

02/05 06:10

Market Cap

145.96B

Beta: 0.20

Volume Today

877.88K

Avg: 727.36K

PE Ratio

28.60

PFCF: 45.53

Dividend Yield

1.86%

Payout:49.33%

OverviewFinancialsAPI

This will be loaded shortly.

Loading

This is also still loading.

This will be loaded shortly.

Loading

This is also still loading.

This will be loaded shortly.

Loading

This is also still loading.

    Description

    CSL Limited researches, develops, manufactures, markets, and distributes biopharmaceutical and allied products in Australia, the United States, Germany, the United Kingdom, Switzerland, China, and internationally. The company operates through two segments, CSL Behring and CSL Seqirus. The CSL Behring segment offers plasma therapies, such as plasma products and recombinants. Thi...Show More

    Excel Tearsheet

    Earnings

    Earnings per Share (Estimate*)

    1234562020-12-312021-12-312023-02-142023-12-312024-10-30

    Revenue (Estimate*)

    2B4B6B8B10B12B2020-12-312021-12-312023-02-142023-12-312024-10-30

    *Estimate based on analyst consensus